IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medexus Pharmaceuticals Inc (MEDXF)

CUSIP: 58410Q203 | NYSE | 2 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Bard Financial Services, Inc.10,000
0.0% of portfolio›$14.1K
StyleTurnoverLocationFiled
Bard Financial Services, Inc.
10,000$14.1K0.0%GrowthVery LowBranford, CT2023-07-11